Lanean...

The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Expert Rev Clin Pharmacol
Egile Nagusiak: Louie, Samuel, Zeki, Amir A, Schivo, Michael, Chan, Andrew L, Yoneda, Ken Y, Avdalovic, Mark, Morrissey, Brian M, Albertson, Timothy E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/
https://ncbi.nlm.nih.gov/pubmed/23473596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!